Medical research

Lancet boosts review process after COVID study retraction

The prestigious Lancet medical journal said it is bolstering its scientific review process after being forced to retract a study into the effects of an anti-arthritis drug on COVID-19 patients.

Oncology & Cancer

Financial disclosure lacking in publication of clinical trials

A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...

page 1 from 3